Free Trial

Connect Biopharma (CNTB) Institutional Ownership

Connect Biopharma logo
$2.05 -0.10 (-4.65%)
Closing price 08/15/2025 04:00 PM Eastern
Extended Trading
$2.12 +0.07 (+3.37%)
As of 08/15/2025 05:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for Connect Biopharma (NASDAQ:CNTB)

Current
Institutional Ownership
Percentage
58.72%
Number of
Institutional Buyers
(last 12 months)
7
Total
Institutional Inflows
(last 12 months)
$567.01K
Number of
Institutional Sellers
(last 12 months)
2
Total
Institutional Outflows
(last 12 months)
$322.55K
Get CNTB Insider Trade Alerts

Want to know when executives and insiders are buying or selling Connect Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

CNTB Institutional Buying and Selling by Quarter

Connect Biopharma Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/12/2025 XTX Topco Ltd28,862$29K0.0%N/A0.052%
8/12/2025 AlphaCore Capital LLC80,000$78K0.0%N/A0.144%
8/11/2025 BML Capital Management LLC1,821,558$1.79M1.4%-13.0%3.278%
7/29/2025 Koa Wealth Management LLC49,600$49K0.0%N/A0.089%
2/13/2025 Renaissance Technologies LLC134,697$186K0.0%-23.2%0.244%
2/3/2025Callan Capital LLC80,000$110K0.0%+91.3%0.145%
1/27/2025 Choreo LLC160,867$204K0.0%N/A0.291%
1/24/2025 Catalina Capital Group LLC47,867$66K0.0%N/A0.087%
11/5/2024 BML Capital Management LLC2,093,232$3.01M1.8%+2.4%3.789%
8/9/2024 Renaissance Technologies LLC212,300$323K0.0%-11.5%0.385%
7/17/2024 Keudell Morrison Wealth Management32,200$49K0.0%+63.5%0.058%
5/7/2024 Keudell Morrison Wealth Management19,700$34K0.0%+75.9%0.036%
1/30/2024 BML Capital Management LLC2,061,438$2.43M1.8%N/A3.743%
8/15/2023 Kynam Capital Management LP535,005$603K0.1%-27.7%0.972%
11/14/2022 Boothbay Fund Management LLC26,867$35K0.0%-65.5%0.049%
8/16/2022 DAFNA Capital Management LLC250,000$218K0.1%N/A0.454%
5/13/2022 Kynam Capital Management LP227,759$688K0.2%N/A0.414%
2/22/2022 DLD Asset Management LP121,707$627K0.0%N/A0.212%
2/15/2022 DLD Asset Management LP121,707$627K0.0%N/A0.212%
2/15/2022 Adage Capital Partners GP L.L.C.1,250,000$6.44M0.0%N/A2.174%
2/14/2022 Altium Capital Management LP175,000$901K0.2%N/A0.304%
2/14/2022 Deep Track Capital LP647,057$3.33M0.2%N/A1.125%
2/11/2022 Ensign Peak Advisors Inc25,412$131K0.0%N/A0.044%
11/16/2021 Janus Henderson Group PLC403,459$9.57M0.0%+3.1%0.702%
11/16/2021 Wellington Management Group LLP1,145,177$27.37M0.0%-25.3%1.991%
11/12/2021Vident Investment Advisory LLC10,851$263K0.0%N/A0.019%
11/9/2021BlackRock Inc.2,450,065$59.37M0.0%-0.3%4.261%
11/5/2021 Daiwa Securities Group Inc.6,069$147K0.0%N/A0.011%
8/17/2021 Millennium Management LLC42,856$837K0.0%+286.1%0.075%
8/17/2021 Old Well Partners LLC122,431$2.39M1.1%N/A0.213%
8/16/2021 RA Capital Management L.P.6,991,003$136.53M2.2%+133.7%12.157%
8/16/2021 Federated Hermes Inc.12,000$234K0.0%-70.0%0.021%
8/13/2021 FMR LLC3,925,836$76.67M0.0%+23.3%6.827%
8/11/2021BlackRock Inc.2,458,132$48.01M0.0%+0.3%4.275%
8/10/2021 Citigroup Inc.1,413$28K0.0%N/A0.002%
5/18/2021 Millennium Management LLC11,099$205K0.0%N/A0.019%
(Data available from 1/1/2016 forward)

CNTB Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of CNTB shares?

During the previous two years, 9 institutional investors and hedge funds held shares of Connect Biopharma. The most heavily invested institutionals were BML Capital Management LLC ($1.79M), Choreo LLC ($204K), Renaissance Technologies LLC ($186K), Callan Capital LLC ($110K), AlphaCore Capital LLC ($78K), Catalina Capital Group LLC ($66K), and Koa Wealth Management LLC ($49K).Learn more on Connect Biopharma's institutional investors.

What percentage of Connect Biopharma's stock is owned by institutional investors?

58.72% of Connect Biopharma's stock is owned by institutional investors. Learn more on CNTB's institutional investor holdings.

Which institutional investors have been buying Connect Biopharma's stock?

The following institutional investors have purchased Connect Biopharma's stock in the last 24 months: BML Capital Management LLC ($2.11M), Choreo LLC ($160.87K), AlphaCore Capital LLC ($80K), Koa Wealth Management LLC ($49.60K), Catalina Capital Group LLC ($47.87K), Callan Capital LLC ($38.18K), and XTX Topco Ltd ($28.86K).

How much institutional buying is happening at Connect Biopharma?

Institutional investors have bought a total of 455,357 shares in the last 24 months. This purchase volume represents approximately $567.01K in transactions.

Which of Connect Biopharma's major shareholders have been selling company stock?

The following institutional investors have sold Connect Biopharma stock in the last 24 months: BML Capital Management LLC ($271.67K), and Renaissance Technologies LLC ($40.80K).

How much institutional selling is happening at Connect Biopharma?

Institutional investors have sold a total of 312,477 shares in the last 24 months. This volume of shares sold represents approximately $322.55K in transactions.



This page (NASDAQ:CNTB) was last updated on 8/17/2025 by MarketBeat.com Staff
From Our Partners